Abstract:Background: Latent tuberculosis infection (LTBI) is the primary source of active tuberculosis (ATB), but there are no specific methods for diagnosing and preventing LTBI. Methods: Dominant T and B cell epitopes predicted from five antigens related to LTBI and Mycobacterium tuberculosis region of difference (LTBI-RD) were used to construct a novel polypeptide molecule (PPM). Then, the physicochemical properties, secondary structure, tertiary structure of the PPM, and its binding ability to toll-like receptor 2 (TLR2) and TLR4 were analyzed by bioinformatics tools. Finally, immune stimulation and expression optimization of the PPM were carried out. Results: Four helper T lymphocytes (HTL) epitopes, five cytotoxic T lymphocytes (CTL) epitopes, and three B cell epitopes were predicted and screened from five LTBI-RD related antigens. These epitopes were connected in series with linkers and adjuvants to construct a novel PPM termed C543P. The results indicated that antigenicity and immunogenicity scores of the C543P candidate were 0.936399 and 1.36469, respectively. The structural analysis results showed that the C543P candidate had good stability. Its secondary structure contained 43.6% α-helix, the Z-score after tertiary structure optimization was −7.9, and the Ramachandran diagram showed that 88.77% amino acid residues of the C543P candidate were in the allowable region. Furthermore, the C543P candidate showed an excellent affinity to TLR2 (−1091.7kcal/mol) and TLR4 (−1102.7kcal/mol). In addition, we also analyzed the immunological characteristics of the C543P candidate. Immune stimulation prediction showed that the C543P candidate could effectively activate T and B lymphocytes and produce high levels of Th1 cytokines such as IFN-γ and IL-2. Conclusion: We constructed a novel PPM with acceptable antigenicity, immunogenicity, stability, and ability to induce robust immune responses. This study provides a new diagnostic biomarker or peptides-based vaccine for LTBI diagnosis and prevention.

Prediction and analysis of the distribution of T cell epitopes encoded by the specific RD12 region of Mycobacterium tuberculosis

Analysis of Predicted T Cell Epitopes from Proteins Encoded by the Specific RD1 Region of Mycobacterium tuberculosis

Analysis of predicted CD8 + T cell epitopes from proteins encoded by the specific RD regions of Mycobacterium tuberculosis for vaccine development and specific diagnosis

Prediction and Identification of HLA-A*0201 Restricted CD8+CTL Epitope in Mycobacterium Tuberculosis Ag85C

In Silico Identification of Cytotoxic T Lymphocyte Epitopes Encoded by RD5 Region of Mycobacterium Tuberculosis.

The prediction of T-and B-combined epitope of Ag 85 B antigen of Mycobacterium tuberculosis

Prediction and Identification of HLA-A* 0201 Restricted CTL Epitopes in Mycobacteriun Tuberculosis Rv0173

Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis

Assessment of the detection effect of specific protein fragment of Rv3388 and six kinds of antigens in tuberculosis antibody response

Assessing and Screening for T-cell Epitopes from Mycobacterium Tuberculosis RD2 Proteins for the Diagnosis of Active Tuberculosis

Epitope Prediction of Rv3873 Gene from Mycobacterium Tuberculosis and Antigenicity Analysis of Related Protein Fragments

Human Cd8(+) T Cells From Tb Pleurisy Respond To Four Immunodominant Epitopes In Mtb Cfp10 Restricted By Hla-B Alleles

Mycobacterium Tuberculosis Peptide E7/HLA-DRB1 Tetramers with Different HLA-DR Alleles Bound CD4+ T Cells Might Share Identical CDR3 Region.

Mycobacterium tuberculosis region of difference (RD) 2 antigen Rv1985c and RD11 antigen Rv3425 have the promising potential to distinguish patients with active tuberculosis from M. bovis BCG-vaccinated individuals.

Analysis of the Antigenic Properties of Membrane Proteins of Mycobacterium Tuberculosis

The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8(+) T-cell epitopes for active pulmonary tuberculosis.

In silico Analysis of Peptide-Based Biomarkers for the Diagnosis and Prevention of Latent Tuberculosis Infection

A Novel B-Cell Epitope Identified Within Mycobacterium Tuberculosis CFP10/ESAT-6 Protein

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

High Immunogenicity of a T-Cell Epitope-Rich Recombinant Protein Rv1566c-444 From Mycobacterium tuberculosis in Immunized BALB/c Mice, Despite Its Low Diagnostic Sensitivity

Identification of Mycobacterium tuberculosis PPE68-Specific HLA-A*0201-Restricted Epitopes for Tuberculosis Diagnosis